Outcomes with Angiotensin-converting Enzyme Inhibitors vs Other Antihypertensive Agents in Hypertensive Blacks

American Journal of Medicine

Volumn 128, Issue 11, 2015, Pages 1195-1203

  Bangalore, Sripal ^a   Ogedegbe, Gbenga ^a,b   Gyamfi, Joyce ^a   Guo, Yu ^a   Roy, Jason ^c   Goldfeld, Keith ^a   Torgersen, Christopher ^a   Capponi, Louis ^a,d   Phillips, Christopher ^e   Shah, Nirav R ^f  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d New York City Health and Hospitals Cooperation   (United States)

^e MOREHOUSE SCHOOL OF MEDICINE   (United States)

^f KAISER FOUNDATION HOSPITAL   (United States)

Author keywords

Angiotensin converting enzyme inhibitors; Blacks; Hypertension

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT; ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL STUDY; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPENSITY SCORE; RISK ASSESSMENT; RISK FACTOR; AFRICAN AMERICAN; AGED; COMPLICATION; ETHNOLOGY; EVALUATION STUDY; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; NEW YORK; STROKE; TREATMENT OUTCOME;

ADULT; AFRICAN AMERICANS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NEW YORK CITY; STROKE; TREATMENT OUTCOME;

EID: 84946491862     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2015.04.034     Document Type: Article

References (33)

1. National Institute for Health and Care Excellence Hypertension: Clinical management of primary hypertension in adults. NICE guidelines [CG127] 2011 National Clinical Guideline Centre London Available at: http://www.nice.org.uk/guidance/cg127 Accessed October 9, 2014
2. P.A. James, S. Oparil, B.L. Carter, and et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8) JAMA 311 2014 507 520
3. G. Mancia, R. Fagard, K. Narkiewicz, and et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) J Hypertens 31 2013 1281 1357
4. S. Yusuf, P. Sleight, J. Pogue, and et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators N Engl J Med 342 2000 145 153
5. S.D. Solomon, D. Wang, P. Finn, and et al. Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program Circulation 110 2004 2180 2183
6. W. Zidek, J. Schrader, S. Luders, and et al. First-line antihypertensive treatment in patients with pre-diabetes: rationale, design and baseline results of the ADaPT investigation Cardiovasc Diabetol 7 2008 22
7. A.L. Taylor, and J.T. Wright Jr. Should ethnicity serve as the basis for clinical trial design? Importance of race/ethnicity in clinical trials: lessons from the African-American Heart Failure Trial (A-HeFT), the African-American Study of Kidney Disease and Hypertension (AASK), and the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Circulation 112 2005 3654 3666
8. J.T. Wright Jr., J.K. Dunn, J.A. Cutler, and et al. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril JAMA 293 2005 1595 1608
9. ALLHAT Officers Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA 288 2002 2981 2997
10. T. Morimoto, T.K. Gandhi, J.M. Fiskio, and et al. An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors J Eval Clin Pract 10 2004 499 509
11. J.T. Wright Jr., G. Bakris, T. Greene, and et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial JAMA 288 2002 2421 2431
12. L.C. Reardon, and D.S. Macpherson Hyperkalemia in outpatients using angiotensin-converting enzyme inhibitors. How much should we worry? Arch Intern Med 158 1998 26 32
13. N.A. Dreyer Good ReseArch for Comparative Effectiveness (GRACE) Principles [November 20, 2008]. Available at: http://www.graceprinciples.com/ 2008 Accessed November 30, 2014
14. W.A. Ray Evaluating medication effects outside of clinical trials: new-user designs Am J Epidemiol 158 2003 915 920
15. P. Rosenbaum, and D. Rubin The central role of propensity score in observational studies for causal effects Biometrika 70 1983 41 55
16. D. Rubin Using propensity score to help design observational studies: application to the tobacco litigation Health Serv Outcomes Res Methodol 2 2001 169 188
17. A. Ahmed, A. Husain, T.E. Love, and et al. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods Eur Heart J 27 2006 1431 1439
18. S.T. Normand, M.B. Landrum, E. Guadagnoli, and et al. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores J Clin Epidemiol 54 2001 387 398
19. K. Hirano, and G. Imbens Estimation of causal effects using propensity score weighting: an application to data on right heart catheterization Health Serv Outcomes Res Methodol 2 2001 259 278
20. J.K. Lunceford, and M. Davidian Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study Stat Med 23 2004 2937 2960
21. I.U. Park, and A.L. Taylor Race and ethnicity in trials of antihypertensive therapy to prevent cardiovascular outcomes: a systematic review Ann Fam Med 5 2007 444 452
22. W.H. Giles, S.J. Kittner, J.R. Hebel, and et al. Determinants of black-white differences in the risk of cerebral infarction. The National Health and Nutrition Examination Survey Epidemiologic Follow-up Study Arch Intern Med 155 1995 1319 1324
23. M.J. Klag, P.K. Whelton, B.L. Randall, and et al. End-stage renal disease in African-American and white men. 16-year MRFIT findings JAMA 277 1997 1293 1298
24. V.N. Pavlik, D.J. Hyman, C. Vallbona, and et al. Hypertension awareness and control in an inner-city African-American sample J Hum Hypertens 11 1997 277 283
25. E. Saunders, M.R. Weir, B.W. Kong, and et al. A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks Arch Intern Med 150 1990 1707 1713
26. B.J. Materson, D.J. Reda, W.C. Cushman, and et al. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents N Engl J Med 328 1993 914 921
27. M.R. Weir, J.M. Gray, R. Paster, and E. Saunders Differing mechanisms of action of angiotensin-converting enzyme inhibition in black and white hypertensive patients. The Trandolapril Multicenter Study Group Hypertension 26 1995 124 130
28. B. Falkner, and H. Kushner Effect of chronic sodium loading on cardiovascular response in young blacks and whites Hypertension 15 1990 36 43
29. W.J. Elliott Higher incidence of discontinuation of angiotensin converting enzyme inhibitors due to cough in black subjects Clin Pharmacol Ther 60 1996 582 588
30. J.M. Flack, D.A. Sica, G. Bakris, and et al. Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement Hypertension 56 2010 780 800
31. Racial differences in response to low-dose captopril are abolished by the addition of hydrochlorothiazide Br J Clin Pharmacol 14 Suppl 2 1982 97S 101S
32. S.J. Middlemost, R. Tager, J. Davis, and P. Sareli Effectiveness of enalapril in combination with low-dose hydrochlorothiazide versus enalapril alone for mild to moderate systemic hypertension in black patients Am J Cardiol 73 1994 1092 1097
33. K. Jamerson, M.A. Weber, G.L. Bakris, and et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients N Engl J Med 359 2008 2417 2428